OCEAN BIOMEDICAL, INC.
OCEACIK 0001869974
Revenue (TTM)
—
Q1 May 2025
Net Income (TTM)
−$18M
−155.9% YoY
Q1 May 2025
EPS Diluted (TTM)
−$0.44
−161.5% YoY
Q1 May 2025
Gross Margin
—
Q1 May 2025
Operating Margin
—
Q1 May 2025
Net Margin
—
Q1 May 2025
Free Cash Flow (TTM)
—
Q1 May 2025
Cash
$0
Q1 May 2025
Total Debt
$3.2M
Q1 May 2025
Shares Outstanding
232.37M sh
Q1 May 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.